Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhongxin Pharmaceutical Group, announced amendments to its Articles of Association and applied for changes in industrial and commercial registration. The company assures the accuracy of the information provided and stands by the resolutions passed in past meetings. These developments highlight the company’s ongoing efforts to align its corporate structure with strategic goals.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.